Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation
Open accessAbstract
The prevalence of atrial fibrillation (AF) in end-stage renal failure is high, with an increased risk of stroke among these patients with AF compared with the AF population without severe renal impairment. Many trials have shown the net clinical benefit of oral anticoagulation therapy for primary and secondary prevention of stroke in patient populations with AF. However, current stroke risk stratification schemes are based on studies that have deliberately excluded patients with severe renal impairment. Indeed, there are no large randomized controlled trials that assess the real risk/benefit of full intensity anticoagulation in patients with severe renal impairment. Also, rates of major bleeding episodes in anticoagulated hemodialysis patients with AF are high. These data are influenced by the lack of appropriate monitoring, the difficulties in maintaining the international normalized ratio target (variable between the studies), and an inaccurate bleeding classification. Thus, the limited available data may be difficult to apply to such a heterogeneous patient population, characterized by both an increased risk of bleeding and a hypercoagulability state, as seen in the patient population with severe renal impairment.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
There are no randomized trials assessing oral anticoagulation in haemodialysis patients, and no controlled trials of NOACs in patients with severe CKD (CrCl < 25-30 mL/min).
“There are no randomized trials assessing OAC in haemodialysis patients, 418 and no controlled trials of NOACs in patients with severe CKD (CrCl < 25-30 mL/min).”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [418]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633 · see citing works
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215 · see citing works
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388 · see citing works
Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M. (2010) · Chest · doi:10.1378/chest.09-1584 · Cited by 6,879 · see citing works
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205 · see citing works
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,875 · see citing works
Heart Disease and Stroke Statistics—2010 Update: A Report From the American Heart Association
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R. J., Brown, T. M., Carnethon, M., Dai, S., De Simone, G., Ferguson, T. B., Ford, E., Furie, K., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192667 · Cited by 5,700 · see citing works
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832 · see citing works
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · CHEST Journal · doi:10.1378/chest.10-0134 · Cited by 4,517 · see citing works
Clinical epidemiology of cardiovascular disease in chronic renal disease
Rn, F., Parfrey, P. S., & Sarnak, M. J. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820470 · Cited by 3,960 · see citing works
Heart Disease and Stroke Statistics—2009 Update
WRITING GROUP MEMBERS, Lloyd‐Jones, D. M., Adams, R. J., Carnethon, M. R., SIMONE, G. D., Ferguson, T. B., Flegal, K. M., Ford, E. S., Furie, K. L., Go, A. S., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191259 · Cited by 3,891 · see citing works
WRITING GROUP MEMBERS, Lloyd-Jones, D., Adams, R., Carnethon, M., De Simone, G., Ferguson, T. B., Flegal, K., Ford, E., Furie, K., Go, A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191261 · Cited by 3,140 · see citing works
Feinberg, W. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.5.469 · Cited by 2,282 · see citing works
Effect of clopidogrel added to aspirin in patients with atrial fibrillation
The ACTIVE Investigators (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901301 · Cited by 2,102 · see citing works
Kannel, W. B., Wolf, P. A., Benjamin, E. J., & Levy, D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00583-9 · Cited by 2,033 · see citing works
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,877 · see citing works
Petersen, P., GODTFREDSEN, J., Boysen, G., Andersen, E. D., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,814 · see citing works
Mant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556 · see citing works
Atrial Fibrillation: A Major Contributor to Stroke in the Elderly
Wolf, P. A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.9.1561 · Cited by 1,526 · see citing works
Goodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474 · see citing works
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
Ezekowitz, M. D., Bridgers, S. L., James, K. E., Carliner, N. H., Colling, C. L., Gornick, C. C., Krause-Steinrauf, H. J., Kurtzke, J. F., Nazarian, S. M., Radford, M. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211123272002 · Cited by 1,204 · see citing works
Fuster, V., Rydén, L., Cannom, D. S., Crijns, H. J. G. M., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Heuzey, J. L., Kay, G. N., Lowe, J. E., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.009 · Cited by 1,157 · see citing works
Canadian atrial fibrillation anticoaguiation (CAFA) study
Connolly, S. J., Laupacis, A., Gent, M., Roberts, R. S., Cairns, J. A., & Joyner, C. D. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90585-w · Cited by 1,109 · see citing works
Atrial Fibrillation: A Major Contributor to Stroke in the Elderly: The Framingham Study
Wolf, P. A. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090041008 · Cited by 1,108 · see citing works
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
Barnes, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301143280227 · Cited by 1,068 · see citing works
Gage, B. F., Yan, Y., Milligan, P. E., Waterman, A. D., Culverhouse, R., Rich, M. W., & Radford, M. J. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.017 · Cited by 1,008 · see citing works
Lipowski, Z. J. (1974) · The Lancet · doi:10.1016/s0140-6736(74)92478-7 · Cited by 944 · see citing works
Hansen, M. L., Sørensen, R., Clausen, M. T., Fog-Petersen, M. L., Raunsø, J., Gadsbøll, N., Gislason, G. H., Folke, F., Andersen, S. S., Schramm, T. K., et al. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.271 · Cited by 855 · see citing works
Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency
Shlipak, M. G., Fried, L. F., Crump, C., Bleyer, A. J., Manolio, T. A., Tracy, R. P., Furberg, C. D., & Psaty, B. M. (2003) · Circulation · doi:10.1161/01.cir.0000042700.48769.59 · Cited by 808 · see citing works
Beyth, R. J., Quinn, L., & Landefeld, C. S. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00198-3 · Cited by 777 · see citing works
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., & Manning, W. J. (2008) · CHEST Journal · doi:10.1378/chest.08-0678 · Cited by 755 · see citing works
Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., Prendergast, B., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq512 · Cited by 555 · see citing works
Wan, Y., Heneghan, C., Perera, R., Roberts, N., Hollowell, J., Glasziou, P., Bankhead, C., & Xu, Y. (2008) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.796185 · Cited by 514 · see citing works
Soliman, E. Z., Prineas, R. J., Go, A. S., Xie, D., Lash, J. P., Rahman, M., OJO, A. O., Teal, V. L., Jensvold, N. G., Robinson, N. L., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.03.027 · Cited by 451 · see citing works
Go, A. S., Fang, M. C., Udaltsova, N. V., Chang, Y., Pomernacki, N. K., Borowsky, L. H., & Singer, D. E. (2009) · Circulation · doi:10.1161/circulationaha.108.816082 · Cited by 447 · see citing works
Chan, K. E., Lazarus, J. M., Thadhani, R., & Hakim, R. M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009030319 · Cited by 431 · see citing works
Wizemann, V., Tong, L., Satayathum, S., Disney, A., Akiba, T., Fissell, R. B., Kerr, P. G., Young, E. W., & Robinson, B. M. (2010) · Kidney International · doi:10.1038/ki.2009.477 · Cited by 408 · see citing works
Kidney Function Influences Warfarin Responsiveness and Hemorrhagic Complications
Limdi, N. A., Beasley, T. M., Baird, M. F., Goldstein, J. A., McGwin, G., Arnett, D. K., Acton, R. T., & Allon, M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070802 · Cited by 294 · see citing works
Garcia, D. A., Libby, E. N., & Crowther, M. A. (2009) · Blood · doi:10.1182/blood-2009-09-241851 · Cited by 288 · see citing works
Dilemmas in the Management of Atrial Fibrillation in Chronic Kidney Disease
Reinecke, H., Brand, E., Mesters, R. M., Diaeresis]bitz, W.-R. D. S., Fisher, M., Diaeresis]dt, H. P., & Breithardt, G. D. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007111207 · Cited by 271 · see citing works
Genovesi, S., Pogliani, D., Faini, A., Valsecchi, M. G., Riva, A., Stefani, F., Acquistapace, I., Stella, A., Bonforte, G., DeVecchi, A., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.07.044 · Cited by 265 · see citing works
Atrial fibrillation and stroke prevention
Lip, G. Y. H., & Lim, H. S. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70264-8 · Cited by 245 · see citing works
New oral anticoagulant drugs in cardiovascular disease
Lip, G. Y. H., Peter, K., & Ahrens, I. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-05-0327 · Cited by 227 · see citing works
Atrial Fibrillation and Morbidity and Mortality in a Cohort of Long-term Hemodialysis Patients
Genovesi, S., Vincenti, A., Rossi, E., Pogliani, D., Acquistapace, I., Stella, A., & Valsecchi, M. G. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.10.034 · Cited by 213 · see citing works
Platelet Function in Renal Failure
Eknoyan, G., Wacksman, S. J., Glueck, H. I., & Will, J. J. (1969) · New England Journal of Medicine · doi:10.1056/nejm196903272801301 · Cited by 210 · see citing works
Major Bleeding in Hemodialysis Patients
Holden, R. M., Harman, G. J. S., Wang, M., Holland, D. C., & Day, A. G. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01810407 · Cited by 188 · see citing works
Warfarin Anticoagulation in Hemodialysis Patients: A Systematic Review of Bleeding Rates
Elliott, M. J., Zimmerman, D. L., & Holden, R. M. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.06.017 · Cited by 182 · see citing works
Abbott, K. C., Trespalacios, F. C., Taylor, A. J., & Agodoa, L. Y. C. (2003) · BMC Nephrology · doi:10.1186/1471-2369-4-1 · Cited by 160 · see citing works
Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis
Vázquez, E., Sánchez-Perales, C., Borrego, F., Garcı́a-Cortes, M. J., Lozano, C., Guzmán, M., Gil, J. M., Borrego, M. J., & Pérez, V. (2000) · American Heart Journal · doi:10.1067/mhj.2000.111111 · Cited by 159 · see citing works
Risk factors for upper gastrointestinal bleeding among end-stage renal disease patients
Wasse, H., Gillen, D. L., Ball, A., Kestenbaum, B. R., Seliger, S. L., Sherrard, D. J., & Stehman‐Breen, C. O. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00225.x · Cited by 156 · see citing works
Decreased Glomerular Filtration Rate Is a Risk Factor for Hemorrhagic But Not for Ischemic Stroke
Bos, M. J., Koudstaal, P. J., Albert Hofman, D., & Breteler, M. M. B. (2007) · Stroke · doi:10.1161/strokeaha.107.489807 · Cited by 153 · see citing works
Risk of major hemorrhage for outpatients treated with warfarin
McMahan, D. A., Smith, D. M., Carey, M. A., & Zhou, X. (1998) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1998.00096.x · Cited by 152 · see citing works
Atrial fibrillation in incident dialysis patients
Vázquez, E., Sánchez-Perales, C., Garcia-Garcia, F., Castellano, P., Garcı́a-Cortes, M. J., Liébana, A., & Lozano, C. (2009) · Kidney International · doi:10.1038/ki.2009.185 · Cited by 134 · see citing works
Vázquez, E., Sánchez-Perales, C., Lozano, C., Garcı́a-Cortes, M. J., Borrego, F., Guzmán, M., Pérez, P., Vilardebó, C. P., Borrego, M. J., & Pérez, V. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00904-4 · Cited by 128 · see citing works
Incidence of Stroke among Chronic Hemodialysis Patients with Nonrheumatic Atrial Fibrillation
Wiesholzer, M., Harm, F., Tomasec, G., Barbieri, G., Putz, D., & Balcke, P. (2001) · American Journal of Nephrology · doi:10.1159/000046216 · Cited by 125 · see citing works
Pengo, V., Zasso, A., Barbero, F., Banzato, A., Nante, G., Parissenti, L., John, N., Noventa, F., & Volta, S. D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00357-9 · Cited by 109 · see citing works
Mokrzycki, M. H., Jean-Jerome, K., Rush, H., Zdunek, M. P., & Rosenberg, S. O. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590051935.x · Cited by 95 · see citing works
Frequency of atrial fibrillation and factors related to its development in dialysis patients
Atar, İ., Konaş, D., Açıkel, S., Külah, E., Atar, A., Bozbaş, H., Gülmez, Ö., Sezer, S., Yı́ldı́rı́r, A., Özdemir, N., et al. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.12.048 · Cited by 94 · see citing works
Tomura, S., Nakamura, Y., Doi, M., Ando, R., Ida, T., Chida, Y., Ootsuka, S., Shinoda, T., Yanagi, H., Tsuchiya, S., et al. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90523-5 · Cited by 88 · see citing works
LeSar, C. J., Merrick, H. W., & Smith, M. R. (1999) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(99)00086-1 · Cited by 80 · see citing works
Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants?
Vázquez, E., Sánchez-Perales, C., Garcı́a-Cortes, M. J., Borrego, F., Lozano, C., Guzmán, M., Gil, J. M., Liébana, A., Pérez, P., Borrego, M. J., et al. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00317-0 · Cited by 79 · see citing works
Das, M., Aronow, W. S., McClung, J. A., & Belkin, R. N. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000148162.88296.9f · Cited by 67 · see citing works
Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis
O’Shea, S. I., Lawson, J. H., Reddan, D. N., Murphy, M. P., & Ortel, T. L. (2003) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(03)00321-5 · Cited by 66 · see citing works
Atrial fibrillation in haemodialysis patients: Do the guidelines for anticoagulation apply?
To, A. C. Y., Yehia, M., & Collins, J. F. (2007) · Nephrology · doi:10.1111/j.1440-1797.2007.00835.x · Cited by 61 · see citing works
The Intersection of Risk and Benefit
Sood, M. M., Komenda, P. V. J., Sood, A. R., Rigatto, C., & Bueti, J. (2009) · CHEST Journal · doi:10.1378/chest.09-0730 · Cited by 53 · see citing works
Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheter (TCC) thrombosis
Colì, L., Donati, G., Cianciolo, G., Raimondi, C., Comai, G., Panicali, L., Nastasi, V., Cannarile, D. C., Gozzetti, F., Piccari, M., et al. (2006) · The Journal of Vascular Access · doi:10.1177/112972980600700305 · Cited by 52 · see citing works
Maintaining Patency of Tunneled Hemodialysis Catheters
Obialo, C. I., Conner, A. C., & Lebon, L. F. (2003) · Scandinavian Journal of Urology and Nephrology · doi:10.1080/00365590310008938 · Cited by 48 · see citing works
Screening and treatment for cardiovascular disease in patients with chronic renal disease
Murphy, S., Foley, R., & Ps, P. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820475 · Cited by 41 · see citing works
Systemic Anticoagulation and Prevention of Hemodialysis Catheter Malfunction
Zellweger, M., Bouchard, J., Raymond-Carrier, S., Laforest-Renald, A., Quérin, S., & Madore, F. O. (2005) · ASAIO Journal · doi:10.1097/01.mat.0000169115.56374.9f · Cited by 41 · see citing works
Böhm, M., Thoenes, M., Neuberger, H., Gräber, S., Reil, J., Bramlage, P., & Volpe, M. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp124 · Cited by 41 · see citing works
The Risk of Anticoagulation in Hemodialysis Patients
Biggers, J. A., Remmers, A. R., Glassford, D. M., Sarles, H. E., Lindley, J. D., & Fish, J. C. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000180784 · Cited by 41 · see citing works
Vascular calcification in chronic kidney disease: the role of vitamin K
Holden, R. M., & Booth, S. L. (2007) · Nature Reviews Nephrology · doi:10.1038/ncpneph0601 · Cited by 40 · see citing works
New Anticoagulants for Atrial Fibrillation
Sobieraj‐Teague, M., O'Donnell, M. J., & Eikelboom, J. W. (2009) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0029-1234147 · Cited by 39 · see citing works
Sachdev, G. P., Ohlrogge, K. D., & Johnson, C. L. (1999) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/56.15.1505 · Cited by 33 · see citing works
Bleeding in patients with renal insufficiency: A practical guide to clinical management
Gangji, A. S., Sohal, A. S., Treleaven, D. J., & Crowther, M. A. (2005) · Thrombosis Research · doi:10.1016/j.thromres.2005.03.029 · Cited by 30 · see citing works
Lip, G. Y. H. (2010) · EP Europace · doi:10.1093/europace/euq427 · Cited by 29 · see citing works
Continuous Murmur After Ascending Aortic Surgery
Manchanda, A., Schiavone, W. A., Lico, S., Poler, S. M., Menapace, F. J., & Nassef, L. A. (2009) · Circulation · doi:10.1161/circulationaha.108.785253 · Cited by 14 · see citing works
Tanaka, H., Sonoda, M., Kashima, K., Tanaka, Y., Nakamura, K., Nuruki, N., & Tsubouchi, H. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-0484 · Cited by 13 · see citing works
Flagged first, then by citations
Research works printed but not linked: 4
- Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2N-9N.
- Pengo V, Zasso A, Barbero F, et al. Effectiveness of fixed minidose warfarin in the prevention of thromboembolism and vascular death in nonrheumatic atrial fibrillation. Am J Cardiol 1998;82:433-7.
- LeSar CJ, Merrick HW, Smith MR. Thrombotic complications resulting from hypercoagulable states in chronic hemodialysis vascular access. J Am Coll Surg 1999;189:73-9.
- Lip GY. Chronic renal disease and stroke in atrial fibrillation: balancing the prevention of thromboembolism and bleeding risk. Europace 2011;13:145-8.
Cited by
Sorted by citations
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438 · see citing works
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418 · see citing works
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,814 · see citing works
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs253 · Cited by 2,898 · see citing works
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403 · see citing works
Heidbüchel, H., Verhamme, P. B., Alings, M., Antz, M., Diener, H., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. F. (2015) · EP Europace · doi:10.1093/europace/euv309 · Cited by 1,114 · see citing works
Stroke and bleeding in atrial fibrillation with chronic kidney disease
Olesen, J. B., Lip, G. Y. H., Kamper, A.-L., Hommel, K., Køber, L., Lane, D. A., Lindhardsen, J., Gislason, G. H., & Torp-Pedersen, C. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105594 · Cited by 930 · see citing works
Herzog, C. A., ASINGER, R. W., Berger, A. K., Charytan, D. M., Dı́ez, J., Hart, R. G., Eckardt, K., Kasiske, B. L., McCullough, P. A., PASSMAN, R. S., et al. (2011) · Kidney International · doi:10.1038/ki.2011.223 · Cited by 918 · see citing works
Heidbuchel, H., Verhamme, P., Alings, M., Antz, M., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. (2013) · Europace · doi:10.1093/europace/eut083 · Cited by 792 · see citing works
Hohnloser, S. H., Hijazi, Z., Thomas, L., Alexander, J. H., Amerena, J., Hanna, M., Keltai, M., Lanas, F., Lopes, R. D., Lopez-Sendon, J., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs274 · Cited by 574 · see citing works
Heidbüchel, H., Verhamme, P. B., Alings, M., Antz, M., Hacke, W., Oldgren, J., Sinnaeve, P., Camm, A. J., & Kirchhof, P. F. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht134 · Cited by 404 · see citing works
Hijazi, Z., Hohnloser, S. H., Oldgren, J., Andersson, U., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Reilly, P. A., Siegbahn, A., Yusuf, S., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.003628 · Cited by 396 · see citing works
Shah, M., Tsadok, M. A., Jackevicius, C. A., Essebag, V., Eisenberg, M. J., Rahme, E., Humphries, K. H., Tu, J. V., Behlouli, H., Guo, H., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.004777 · Cited by 336 · see citing works
Bonde, A. N., Lip, G. Y. H., Kamper, A., Hansen, P. R., Lamberts, M., Hommel, K., Hansen, M. L., Gislason, G., Torp-Pedersen, C. T., & Olesen, J. B. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.051 · Cited by 284 · see citing works
Dahal, K. B., Kunwar, S., Rijal, J. P., Schulman, P. M., & Lee, J. (2015) · CHEST Journal · doi:10.1378/chest.15-1719 · Cited by 224 · see citing works
Klijn, C. J. M., Paciaroni, M., Berge, E., Korompoki, E., Kõrv, J., Lal, A., Jukka Putaala, A., & Werring, D. J. (2019) · European Stroke Journal · doi:10.1177/2396987319841187 · Cited by 213 · see citing works
Warfarin in atrial fibrillation patients with moderate chronic kidney disease
Hart, R. G., Pearce, L. A., Asinger, R. W., & Herzog, C. A. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.02400311 · Cited by 204 · see citing works
Hijazi, Z., Hohnloser, S. H., Andersson, U., Alexander, J. H., Hanna, M., Keltai, M., Parkhomenko, A. N., Lopez-Sendon, J. L., Lópes, R. D., Siegbahn, A., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.1170 · Cited by 174 · see citing works
Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Dialysis
Kuno, T., Takagi, H., Ando, T., Sugiyama, T., Miyashita, S., Valentin, N., Shimada, Y. J., Kodaira, M., Numasawa, Y., Briasoulis, Α., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.10.059 · Cited by 173 · see citing works
Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why?
Lip, G. Y. H. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs435 · Cited by 159 · see citing works
‘Real-World’ Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey
Lip, G. Y. H., Laroche, C., Dan, G., Santini, M., Kalarus, Z. F., Rasmussen, L. H., Ioachim, P. M., Țica, O., Boriani, G., Cimaglia, P., et al. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.12.022 · Cited by 156 · see citing works
Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease
Lau, Y. C., Proietti, M., Guiducci, E., Blann, A. D., & Lip, G. Y. H. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.06.057 · Cited by 144 · see citing works
Kimachi, M., Furukawa, T. A., Kimachi, K., Goto, Y., Fukuma, S., & Fukuhara, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011373.pub2 · Cited by 143 · see citing works
Culebras, A., Messe, S. R., Chaturvedi, S., Kase, C. S., & Gronseth, G. (2014) · Neurology · doi:10.1212/wnl.0000000000000145 · Cited by 131 · see citing works
Chang, C., Lee, Y., Tsai, C., Chang, S., Chung, Y., Lin, M.-S., Lin, J., & Lai, M. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.036 · Cited by 131 · see citing works
Buiten, M. S., de Bie, M. K., Rotmans, J. I., Gabreëls, B. A., van Dorp, W., Wolterbeek, R., Trines, S. A., Schalij, M. J., Jukema, J. W., Rabelink, T. J., et al. (2014) · Heart · doi:10.1136/heartjnl-2013-305417 · Cited by 119 · see citing works
Roldán, V., Marín, F., Fernández, H., Manzano-Fernández, S., Gallego, P., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.12.045 · Cited by 117 · see citing works
Atrial Fibrillation and Ischemic Stroke: A Clinical Review
Migdady, I., Russman, A., & Buletko, A. B. (2021) · Seminars in Neurology · doi:10.1055/s-0041-1726332 · Cited by 121 · see citing works
Renal Impairment and Ischemic Stroke Risk Assessment in Patients With Atrial Fibrillation
Banerjee, A., Fauchier, L., Vourc’h, P., Andres, C. R., Taillandier, S., Halimi, J., & Lip, G. Y. H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.035 · Cited by 112 · see citing works
Roldán, V., Marín, F. R., Manzano‐Fernández, S., Fernández, H., Gallego, P., Valdés, M., Vicente, V., & Lip, G. Y. H. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-01-0054 · Cited by 112 · see citing works
Albertsen, I. E., Rasmussen, L. H., Overvad, T. F., Graungaard, T., Larsen, T. B., & Lip, G. Y. H. (2013) · Stroke · doi:10.1161/strokeaha.113.000883 · Cited by 101 · see citing works
Self-citationStroke in atrial fibrillation: epidemiology and thromboprophylaxis
Lip, G. Y. H. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04302.x · Cited by 91 · see citing works
Nielsen, P. B., Lane, D. A., Rasmussen, L. H., Lip, G. Y. H., & Larsen, T. B. (2014) · Clinical Research in Cardiology · doi:10.1007/s00392-014-0797-9 · Cited by 92 · see citing works
Poulsen, B. K., Grove, E. L., & Husted, S. (2012) · Drugs · doi:10.2165/11635730-000000000-00000 · Cited by 87 · see citing works
Apostolakis, S. Z., Guo, Y., Lane, D. A., Buller, H. R., & Lip, G. Y. H. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht328 · Cited by 87 · see citing works
Banerjee, A., Fauchier, L., Vourc’h, P., Andres, C. R., Taillandier, S., Halimi, J., & Lip, G. Y. H. (2013) · CHEST Journal · doi:10.1378/chest.13-2103 · Cited by 86 · see citing works
Atrial Fibrillation in CKD: Balancing the Risks and Benefits of Anticoagulation
Ng, K. P., Edwards, N. C., Lip, G. Y. H., Townend, J., & Ferro, C. J. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.02.381 · Cited by 82 · see citing works
Anticoagulants in atrial fibrillation patients with chronic kidney disease
Hart, R. G., Eikelboom, J. W., Ingram, A. J., & Herzog, C. A. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.160 · Cited by 75 · see citing works
Andò, G., & Capranzano, P. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.303 · Cited by 79 · see citing works
Szymański, F. M., Lip, G. Y. H., Filipiak, K. J., Platek, A. E., Szymańska, A., & Opolski, G. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.08.049 · Cited by 73 · see citing works
MacCallum, P. K., Mathur, R., Hull, S., Saja, K., Green, L., Morris, J. K., & Ashman, N. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003343 · Cited by 71 · see citing works
Novel Oral Anticoagulants in Patients With Renal Insufficiency: A Meta-analysis of Randomized Trials
Sardar, P., Chatterjee, S., Herzog, E., Nairooz, R. S., Mukherjee, D., & Halperin, J. L. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.04.015 · Cited by 70 · see citing works
Anticoagulation in Chronic Hemodialysis: Progress Toward an Optimal Approach
Kessler, M., Moureau, F., & Nguyên, P. (2015) · Seminars in Dialysis · doi:10.1111/sdi.12380 · Cited by 71 · see citing works
Ruiz-Nodar, J. M., Marín, F. R., Roldán, V., Valencia, J., Manzano‐Fernández, S., Caballero, L., Hurtado, J. A., Sogorb, F., Valdés, M., & Lip, G. Y. H. (2012) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.112.968792 · Cited by 67 · see citing works
Oral Anticoagulation in the Elderly and Frail
Bauersachs, R. M., & Herold, J. (2020) · Hämostaseologie · doi:10.1055/s-0040-1701476 · Cited by 60 · see citing works
Pilgrim, T., Kalesan, B., Zanchin, T., Pulver, C., Jung, S. C., Mattle, H. P., Carrel, T. P., Moschovitis, A., Stortecky, S., Wenaweser, P., et al. (2013) · EuroIntervention · doi:10.4244/eijv8i9a163 · Cited by 58 · see citing works
Stroke prevention strategies in high-risk patients with atrial fibrillation
Kotalczyk, A., Mazurek, M., Kalarus, Z. F., Potpara, T., & Lip, G. Y. H. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00459-3 · Cited by 60 · see citing works
Guo, Y., Wang, H., Zhao, X., Zhang, Y., Zhang, D., Ma, J., Wang, Y., & Lip, G. Y. H. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.179 · Cited by 53 · see citing works
Oral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk
Potpara, T., & Lip, G. Y. H. (2015) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2015.07.003 · Cited by 51 · see citing works
Evidence for the Prevention and Treatment of Stroke in Dialysis Patients
Herrington, W. G., Haynes, R., Staplin, N., Emberson, J., Baigent, C., & Landray, M. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12281 · Cited by 51 · see citing works
Thromboembolic Prevention in Frail Elderly Patients With Atrial Fibrillation: A Practical Algorithm
Granziera, S., Cohen, A. T., Nante, G., Manzato, E., & Sergi, G. (2015) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.12.008 · Cited by 50 · see citing works
Cardiovascular Risk Assessment Before and After Kidney Transplantation
Glicklich, D., & Vohra, P. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000012 · Cited by 49 · see citing works
Biomarkers in atrial fibrillation: an overview
Vilchez, J. A., Roldán, V., Hernández‐Romero, D., Valdés, M., Lip, G. Y. H., & Marín, F. R. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12304 · Cited by 47 · see citing works
Warfarin Use in Patients With Atrial Fibrillation Undergoing Hemodialysis
Yoon, C.-Y., Noh, J., Jhee, J. H., Chang, T. I., Kang, E. W., Kee, Y. K., Kim, H., Park, S., Yun, H., Jung, S.-Y., et al. (2017) · Stroke · doi:10.1161/strokeaha.117.017114 · Cited by 46 · see citing works
Morbidity and treatment in patients with atrial fibrillation and chronic kidney disease
Reinecke, H., Näbauer, M., Gerth, A., Limbourg, T., Treszl, A., Engelbertz, C. M., Eckardt, L., Kirchhof, P. F., Wegscheider, K., Ravens, U., et al. (2014) · Kidney International · doi:10.1038/ki.2014.195 · Cited by 45 · see citing works
Abe, M., Ogawa, H., Ishii, M., Masunaga, N., Esato, M., Chun, Y., Tsuji, H., Wada, H., Hasegawa, K., Lip, G. Y. H., et al. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.01.005 · Cited by 45 · see citing works
The Emerging Role of Biomarkers in Atrial Fibrillation
Kornej, J., Apostolakis, S. Z., Bollmann, A., & Lip, G. Y. H. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.04.016 · Cited by 44 · see citing works
Vanholder, R. C., Laecke, S. V., Glorieux, G., Verbeke, F., Castillo-Rodríguez, E., & Ortíz, A. (2018) · Toxins · doi:10.3390/toxins10060237 · Cited by 43 · see citing works
Evidence Gaps in the Era of Non–Vitamin K Oral Anticoagulants
Aronis, K. N., & Hylek, E. M. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007338 · Cited by 45 · see citing works
New anticoagulant treatments to protect against stroke in atrial fibrillation
Potpara, T., Lip, G. Y. H., & Apostolakis, S. Z. (2012) · Heart · doi:10.1136/heartjnl-2012-301841 · Cited by 41 · see citing works
Relation Between Serum Uric Acid to Albumin Ratio and Severity of Chronic Coronary Artery Disease
Yalçınkaya, D., Karacali, K., Ilhan, B. C., & Yarlıoğlueş, M. (2023) · Angiology · doi:10.1177/00033197231161902 · Cited by 37 · see citing works
Barra, S., Almeida, I. G., Caetano, F., Providencia, R. A., Paiva, L., Dinis, P., & Marques, A. L. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.06.025 · Cited by 37 · see citing works
Reinecke, H., Juergensmeyer, S., Engelbertz, C. M., Gerß, J., Kirchhof, P. F., BREITHARDT, G. E., Bauersachs, R. M., & Wanner, C. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-022690 · Cited by 37 · see citing works
Shin, S. Y., Han, S. J., Kim, J. S., Im, S. I., Shim, J., Ahn, J., Lee, E. M., Park, Y. M., Kim, J. H., Lip, G. Y. H., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012697 · Cited by 36 · see citing works
Novel oral anticoagulants in patients with chronic kidney disease and atrial fibrillation
Stamellou, E., & Floege, J. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx322 · Cited by 35 · see citing works
Lin, Y., Chen, B.-L., Shih, C., Lin, F., Chen, C., Hsu, C., Kao, Y., Bi, W., Chen, L.-Y., Chien, L., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249940 · Cited by 34 · see citing works
Providencia, R. A., Fernandes, A. S., Paiva, L., Faustino, A., Barra, S., Botelho, A., Trigo, J., Nascimento, J. H. M., & Leitão‐Marques, A. (2012) · Cardiology · doi:10.1159/000345434 · Cited by 34 · see citing works
Clase, C. M., Holden, R. M., Sood, M. M., Rigatto, C., MOIST, L. M., Thomson, A. B. R., Mann, J. F. E., & Zimmerman, D. L. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs346 · Cited by 32 · see citing works
Bautista, J. M. S., Bella, A., Chaudhari, A., Pekler, G., Sapra, K. J., Carbajal, R., & Baumstein, D. I. (2015) · Clinical Kidney Journal · doi:10.1093/ckj/sfv006 · Cited by 32 · see citing works
An evaluation of oral dabigatran etexilate pharmacokinetics and pharmacodynamics in hemodialysis
Wilson, J.-A. S., Goralski, K. B., Soroka, S. D., Morrison, M. J., Mossop, P., Sleno, L., Wang, Y., & Anderson, D. R. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.335 · Cited by 29 · see citing works
Effectiveness and Safety of Warfarin in Dialysis Patients With Atrial Fibrillation
Liu, G., Long, M., Hu, X., Hu, C.-H., Liao, X., Du, Z.-M., & Dong, Y. (2015) · Medicine · doi:10.1097/md.0000000000002233 · Cited by 29 · see citing works
Bhatia, H. S., Hsu, J. C., & Kim, R. J. (2018) · Clinical Cardiology · doi:10.1002/clc.23085 · Cited by 28 · see citing works
Safety and Efficacy of DOACs in Patients with Advanced and End-Stage Renal Disease
Rogula, S., Gąsecka, A., Mazurek, T., Navarese, E. P., Szarpak, Ł., & Filipiak, K. J. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19031436 · Cited by 29 · see citing works
Brancaccio, D., Neri, L., Bellocchio, F., Barbieri, C., Amato, C., Mari, F., Canaud, B., & Stuard, S. (2016) · American Journal of Nephrology · doi:10.1159/000448898 · Cited by 27 · see citing works
Mitsuma, W., Matsubara, T., Hatada, K., Imai, S., Saito, N., Shimada, H., & Miyazaki, S. (2015) · Journal of Cardiology · doi:10.1016/j.jjcc.2015.08.023 · Cited by 27 · see citing works
Warfarin Use and Risk of Stroke in Patients With Atrial Fibrillation Undergoing Hemodialysis
Lee, M., Saver, J. L., Hong, K., Wu, Y., Huang, W.-H., Rao, N. M., & Ovbiagele, B. I. (2016) · Medicine · doi:10.1097/md.0000000000002741 · Cited by 27 · see citing works
Lip, G. Y. H., Connolly, S. J., Yusuf, S., Shestakovska, O., Flaker, G., Hart, R. G., Lanas, F. T., Xavier, D., & Eikelboom, J. W. (2013) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.112.975847 · Cited by 27 · see citing works
Novel Oral Anticoagulants in Cardiovascular Disease
Gallego, P., Roldán, V., & Lip, G. Y. H. (2013) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248413501392 · Cited by 27 · see citing works
Violi, F., Pastori, D., Perticone, F., Hiatt, W. R., Sciacqua, A., Basili, S., Proietti, M., Corazza, G. R., Lip, G. Y. H., & Pignatelli, P. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008026 · Cited by 25 · see citing works
Safety of Edoxaban 30 mg in Elderly Patients with Severe Renal Impairment
Fazio, G., Dentamaro, I., Gambacurta, R., Alcamo, P., & Colonna, P. (2018) · Clinical Drug Investigation · doi:10.1007/s40261-018-0693-6 · Cited by 25 · see citing works
Erratum: Balancing ischaemia and bleeding risks with novel oral anticoagulants
Baber, U., Mastoris, I., & Mehran, R. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.204 · Cited by 24 · see citing works
Balancing ischaemia and bleeding risks with novel oral anticoagulants
Baber, U., Mastoris, I., & Mehran, R. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.170 · Cited by 24 · see citing works
Improving Outcomes in Patients with Lupus and End‐Stage Renal Disease
Inda-Filho, A. J., Neugarten, J., Putterman, C., & Broder, A. R. (2013) · Seminars in Dialysis · doi:10.1111/sdi.12122 · Cited by 24 · see citing works
Wieloch, M., Jönsson, K. M., Själander, A., Lip, G. Y. H., Eriksson, N., & Svensson, P. J. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.01.006 · Cited by 21 · see citing works
Stroke Prevention in Atrial Fibrillation
Mtwesi, V., & Amit, G. (2019) · Medical Clinics of North America · doi:10.1016/j.mcna.2019.05.006 · Cited by 21 · see citing works
Apixaban in renal insufficiency: successful navigation between the Scylla and Charybdis
Steffel, J., & Hindricks, G. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs267 · Cited by 21 · see citing works
Impact of Renal Dysfunction on Clinical Outcome in Patients With Low Risk of Atrial Fibrillation
Lin, W., Lin, Y., Chung, F., Chao, T., Liao, J., Chang, S., Lo, L., Hu, Y., Chiang, C., Cheng, S., et al. (2014) · Circulation Journal · doi:10.1253/circj.cj-13-1246 · Cited by 20 · see citing works
Anticoagulant and antiplatelet therapy in patients with chronic kidney disease
Harmon, J. P., Zimmerman, D. L., & Zimmerman, D. L. (2013) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0b013e328365adca · Cited by 19 · see citing works
Stroke Prophylaxis in Patients with Atrial Fibrillation and End-Stage Renal Disease
van Zyl, M., Abdullah, H. M. A., Noseworthy, P. A., & Siontis, K. C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9010123 · Cited by 19 · see citing works
Rosanio, S., Keylani, A. M., D'Agostino, D. C., Delaughter, C., & Vitarelli, A. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.04.179 · Cited by 18 · see citing works
Personalizing oral anticoagulant treatment in patients with atrial fibrillation
Capranzano, P., Miccichè, E., D’Urso, L., Privitera, F., & Tamburino, C. (2013) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2013.818819 · Cited by 18 · see citing works
Cambronero, F., Martínez, C. C., Hurtado-Martínez, J. A., Marín, F. R., Pastor‐Pérez, F. J., Mateo-Martínez, A., Sánchez‐Martínez, M., Pinar-Bermúdez, E., Valdés, M., & Manzano‐Fernández, S. (2011) · Thrombosis and Haemostasis · doi:10.1160/th11-08-0524 · Cited by 17 · see citing works
Hijazi, Z., Alexander, J. H., Li, Z., WOJDYLA, D. M., Mehran, R., Granger, C. B., Parkhomenko, A. N., Bahit, M. C., Windecker, S., Aronson, R., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.051020 · Cited by 17 · see citing works
Actualización detallada de las guías de la ESC para el manejo de la fibrilación auricular de 2012
Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., Baumgartner, H., et al. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.11.001 · Cited by 16 · see citing works
Vio, R., Proietti, R., Rigato, M., & Calò, L. A. (2021) · Pharmaceuticals · doi:10.3390/ph14030279 · Cited by 16 · see citing works
Yamashita, Y., Takagi, D., Hamatani, Y., Iguchi, M., Masunaga, N., Esato, M., Chun, Y., Itoh, H., Nishimura, M., Wada, H., et al. (2016) · Heart and Vessels · doi:10.1007/s00380-016-0818-x · Cited by 15 · see citing works
Stroke Prevention in Patients With Atrial Fibrillation and Renal Dysfunction
Kaatz, S. S., & Mahan, C. E. (2014) · Stroke · doi:10.1161/strokeaha.114.005117 · Cited by 14 · see citing works
Pelliccia, F., Rosanio, S., Marazzi, G., Poggi, S., Tanzilli, A., Greco, C., Gaudio, C., & Rosano, G. M. C. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.129 · Cited by 14 · see citing works
Santarpia, G., Curcio, A., Sibilio, G., & Indolfi, C. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0319 · Cited by 14 · see citing works
DEEDWANIA, P. C., & Huang, G. W. (2012) · Core evidence · doi:10.2147/ce.s25637 · Cited by 13 · see citing works
- Authors
- Marinigh, R., Lane, D. A., & Lip, G. Y. H.
- Affiliations
- University of Trieste (IT)
- Birmingham City Hospital (GB)
- Corresponding author
- Lip, Gregory Y.H.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2011-03
- Volume
- 57
- Issue
- 12
- Pages
- 1339-1348
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2163399076
- Cited by
- 195
- References
- 79
- Citations by year
- 2026: 2 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 13 · 2020: 7 · 2019: 12 · 2018: 11 · 2017: 12 · 2016: 18 · 2015: 18 · 2014: 25 · 2013: 35 · 2012: 25
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Bayer Healthcare
- AstraZeneca
- Boehringer
- Bayer
- Pfizer/BMS
- Biotronic
- Astellas
- Sanofi
- Cardiome
- Merck
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- atrial fibrillation, severe renal impairment, end-stage renal disease, stroke prevention, oral anticoagulation, hemodialysis, major bleeding, stroke risk stratification, INR monitoring, hypercoagulability
- MeSH terms
- Algorithms, Anticoagulants, Atrial Fibrillation, Renal Dialysis, Hemorrhage, Humans, Kidney Failure, Chronic, Thromboembolism, Comorbidity, Risk Assessment, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
